Manish Shukla

Mr. Manish Shukla

Centre for Ocular Research and Education, University of Waterloo
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Acta Biomaterialia
Verified
Journal Article
Closed access
FMFurqan A. Maulvi
Furqan A. Maulvi
RPRahul J. Patil
Rahul J. Patil
ADAnkita R. Desai
Ankita R. Desai
Manish ShuklaManish Shukla
Manish Shukla
RVRutvi J. Vaidya
Rutvi J. Vaidya
DSDinesh O. Shah
Dinesh O. Shah

1 September 2018 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
FMFurqan A. Maulvi
Furqan A. Maulvi
SSSulabh S. Singhania
Sulabh S. Singhania
ADAnkita R. Desai
Ankita R. Desai
Manish ShuklaManish Shukla
Manish Shukla
ATAniruddha S. Tannk
Aniruddha S. Tannk
DSDinesh O. Shah
Dinesh O. Shah

1 February 2020 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
SPSonia S. Pandey
Sonia S. Pandey
FMFurqan A. Maulvi
Furqan A. Maulvi
PPPriya S. Patel
Priya S. Patel
Manish ShuklaManish Shukla
Manish Shukla
KSKinjal M. Shah
Kinjal M. Shah
DSDinesh O. Shah
Dinesh O. Shah

1 July 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
FMFurqan A. Maulvi
Furqan A. Maulvi
RPRiya J. Parmar
Riya J. Parmar
Manish ShuklaManish Shukla
Manish Shukla
ADAnkita R. Desai
Ankita R. Desai
DDDitixa T. Desai
Ditixa T. Desai
DSDinesh O. Shah
Dinesh O. Shah

1 January 2020 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
FMFurqan A. Maulvi
Furqan A. Maulvi
LPLakshmi V. Pillai
Lakshmi V. Pillai
KPKajal P. Patel
Kajal P. Patel
ADAnkita R. Desai
Ankita R. Desai
Manish ShuklaManish Shukla
Manish Shukla
DSDinesh O. Shah
Dinesh O. Shah

25 February 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Chau-Minh PhanChau-Minh Phan
Chau-Minh Phan
Manish ShuklaManish Shukla
Manish Shukla
HWHendrik Walther
Hendrik Walther
MHMiriam Heynen
Miriam Heynen
DSDavid Suh
David Suh
Lyndon JonesLyndon Jones
Lyndon Jones
Purpose: The purpose of this study was to develop an advanced in vitro blink model that can be used to examine the release of a wide variety of components (for example, topical ophthalmic drugs, comfort-inducing agents) from soft contact lenses. Methods: The model was designed using computer-aided design software and printed using a stereolithography 3D printer. The eyelid and eyeball were synthesized from polyvinyl alcohol and silicone material, respectively. Simulated tear fluid was infused through tubing attached to the eyelid using a syringe pump. With each blink cycle, the eyelid slides and flexes across the eyeball to create an artificial tear film layer. The flow-through fluid was collected using a specialized trough. Two contact lenses, etafilcon A and senofilcon A, were incubated in 2 mL of a water-soluble red dye for 24 h and then placed on the eye model (n = 3). The release of the dye was measured over 24 h using a tear flow rate of 5 µL/min. Results: Approximately 25% of the fluid that flowed over the eye model was lost due to evaporation, nonspecific absorption, and residual dead volume. Senofilcon A absorbed more dye (47.6 ± 2.7 µL) than etafilcon A (22.3 ± 2.0 µL). For etafilcon A, the release of the dye followed a burst-plateau profile in the vial but was sustained in the eye model. For senofilcon A, the release of the dye was sustained in both the vial and the eye model, though more dye was released in the vial (p < 0.05). Overall, the release of the dye from the contact lenses was higher in the vial compared with the eye model (p < 0.05). Conclusion: The blink model developed in this study could be used to measure the release of topical ophthalmic drugs or comfort agents from contact lenses. Simulation of a blink mechanism, an artificial tear film, and nonspecific absorption in an eye model may provide better results than a simple, static vial incubation model.